AdvisorNet Financial, Inc - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 105 filers reported holding ANTARES PHARMA INC in Q3 2018. The put-call ratio across all filers is 1.59 and the average weighting 0.1%.

Quarter-by-quarter ownership
AdvisorNet Financial, Inc ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q3 2020$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q2 2020$34,000
+17.2%
12,2200.0%0.00%0.0%
Q1 2020$29,000
-49.1%
12,2200.0%0.00%
-40.0%
Q4 2019$57,000
+39.0%
12,2200.0%0.01%
+25.0%
Q3 2019$41,000
+2.5%
12,2200.0%0.00%0.0%
Q2 2019$40,000
+8.1%
12,2200.0%0.00%
-20.0%
Q1 2019$37,000
+12.1%
12,2200.0%0.01%0.0%
Q4 2018$33,000
-19.5%
12,2200.0%0.01%0.0%
Q3 2018$41,000
+28.1%
12,2200.0%0.01%
+25.0%
Q2 2018$32,000
+18.5%
12,2200.0%0.00%0.0%
Q1 2018$27,000
+12.5%
12,2200.0%0.00%0.0%
Q4 2017$24,00012,2200.00%
Other shareholders
ANTARES PHARMA INC shareholders Q3 2018
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 6,400,000$13,312,0004.78%
GREAT POINT PARTNERS LLC 2,800,000$5,824,0002.27%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 18,389,789$38,251,0001.27%
WILLIAM HARRIS INVESTORS INC 1,534,283$3,191,0000.89%
Broadfin Capital, LLC 7,575,000$15,756,0000.85%
Lombard Odier Asset Management (USA) Corp 1,000,000$2,080,0000.15%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,665,738$3,465,0000.14%
JW Asset Management, LLC 142,198$296,0000.09%
Donald L. Hagan, LLC 44,000$92,0000.09%
DAFNA Capital Management LLC 45,000$94,0000.08%
View complete list of ANTARES PHARMA INC shareholders